Retention Disorder, Cognitive
1 clinical trials · Condition
◉ Watch Retention Disorder, Cognitive
| Record | Firm | Date |
|---|---|---|
| Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems (NCT01261741) | Merz Pharmaceuticals GmbH | 2010-11-01 |
Track Retention Disorder, Cognitive automatically
Every clearance here is in the API, with alerts when new ones post.